ID JHUEM-14 AC CVCL_4654 SY JHUEM14 DR CLO; CLO_0050877 DR BioSample; SAMN03472023 DR RCB; RCB2225 DR Wikidata; Q54898913 RX PubMed=29872505; CC Population: Japanese. CC Omics: Transcriptome analysis by microarray. CC Derived from site: In situ; Endometrium; UBERON=UBERON_0001295. ST Source(s): RCB=RCB2225 ST Amelogenin: X ST CSF1PO: 12,13,14 ST D13S317: 8,10 ST D16S539: 10 ST D5S818: 11 ST D7S820: 10 ST TH01: 6,10 ST TPOX: 10,11 ST vWA: 17 DI NCIt; C7359; Endometrial adenocarcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 44Y CA Cancer cell line DT Created: 04-04-12; Last updated: 02-05-24; Version: 14 // RX PubMed=29872505; DOI=10.18632/oncotarget.25349; PMCID=PMC5973852; RA Takeshita S., Yamashita Y., Shiomi K., Suzuki N., Yoshida J., RA Naiki-Ito A., Suzuki S., Akatsuka S., Toyokuni S., Takahashi T., RA Mase S., Arakawa A., Sugiura-Ogasawara M., Takahashi S.; RT "Expression of P-REX2a is associated with poor prognosis in RT endometrial malignancies."; RL Oncotarget 9:24778-24786(2018). //